ArticleCureus2021

COVID-19 Coronavirus-Induced Atypical Pneumonia: Efficacy of the Monoclonal Antibody Bevacizumab in Moderate to Severe Cases.

Greshaben Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.